BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31173991)

  • 61. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders.
    Ianiro G; Segal JP; Mullish BH; Quraishi MN; Porcari S; Fabiani G; Gasbarrini A; Cammarota G
    Future Microbiol; 2020 Aug; 15():1173-1183. PubMed ID: 32954843
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Current and future applications of fecal microbiota transplantation for children.
    Chen CC; Chiu CH
    Biomed J; 2022 Feb; 45(1):11-18. PubMed ID: 34781002
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
    Chapman BC; Moore HB; Overbey DM; Morton AP; Harnke B; Gerich ME; Vogel JD
    J Trauma Acute Care Surg; 2016 Oct; 81(4):756-64. PubMed ID: 27648772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.
    Laffin M; Millan B; Madsen KL
    Gut Microbes; 2017 May; 8(3):221-224. PubMed ID: 28059612
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fecal microbiota transplantation for the management of Clostridium difficile infection.
    Rao K; Young VB
    Infect Dis Clin North Am; 2015 Mar; 29(1):109-22. PubMed ID: 25677705
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.
    Kelly BJ; Tebas P
    Chest; 2018 Jan; 153(1):266-277. PubMed ID: 28923757
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clostridioides difficile infection in inflammatory bowel disease: a clinical review.
    Tang M; Wang C; Xia Y; Tang J; Wang J; Shen L
    Expert Rev Anti Infect Ther; 2024 May; 22(5):297-306. PubMed ID: 38676422
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pros and cons: Is faecal microbiota transplantation a safe and efficient treatment option for gut dysbiosis?
    Marrs T; Walter J
    Allergy; 2021 Jul; 76(7):2312-2317. PubMed ID: 33483999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection.
    Singh R; Nieuwdorp M; ten Berge IJ; Bemelman FJ; Geerlings SE
    Clin Microbiol Infect; 2014 Nov; 20(11):1119-25. PubMed ID: 25274035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Review Article: Gastroenterology and Clostridium difficile Infection: Past, Present, and Future.
    Kelly CR; Allegretti JR
    Clin Infect Dis; 2023 Dec; 77(Suppl 6):S463-S470. PubMed ID: 38051967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
    Tang G; Yin W; Liu W
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders].
    Li N; Tian H; Ma C; Ding C; Ge X; Gu L; Zhang X; Yang B; Hua Y; Zhu Y; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):40-46. PubMed ID: 28105618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic manipulation of the microbiota: past, present, and considerations for the future.
    Young VB
    Clin Microbiol Infect; 2016 Nov; 22(11):905-909. PubMed ID: 27619640
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
    Stallmach A; Reuken PA; Teich N
    Z Gastroenterol; 2018 Nov; 56(11):1369-1377. PubMed ID: 30419580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection.
    Brandt LJ
    Psychosom Med; 2017 Oct; 79(8):868-873. PubMed ID: 28976455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.